Glasgow Scientists Set to Lead New Era in Pancreatic Cancer Treatment

Glasgow Scientists Set to Lead New Era in Pancreatic Cancer Treatment

Friday 24 March 2017

Scotland’s investments create a launch-pad for ambitious large-scale programmes in Precision Medicine. Investments from Scotland’s CSO, SMS-IC and the Scottish Precision Medicine Ecosystem funding has helped access £10m funding from Cancer Research UK for pioneering research: PRECISION Panc led by Professor Andrew Biankin at Glasgow University. Read CRUK’s press release here.

Share this

Back to news